Viewing posts for the category SomnoMed (ASX:SOM)

SomnoMed Limited (ASX:SOM) continues to grow: Musings on the 2014 results

SomnoMed Limited yesterday reported a fully year revenue increase of nearly 40%, to $25.9 million on the back of increased sales of its medical devices which are designed to treat the milder forms of sleep apnoea . However, the company also reported a substantial reduction of net profit after tax, due in large part to slightly decreased gross profit margins and increased general administration expenditure.

read more